Quarterly ResultAug 5, 2026, 06:07 AM
Palomino Labs H1 2026 Net Loss $2.61M; Cash Up to $19.44M
AI Summary
Palomino Laboratories Inc. reported a net loss of $2.61 million for the six months ended June 30, 2026, compared to a net loss of $0.60 million in the prior year period. The company, a fabless semiconductor firm in the development stage, saw its cash and cash equivalents increase significantly to $19.44 million as of June 30, 2026, up from $8.12 million at December 31, 2025, primarily due to $14.82 million in financing activities. Despite increased operating expenses, including $1.11 million in research and development, management believes current cash is sufficient for at least one year.
Key Highlights
- Net loss for H1 2026 was $2.61 million, compared to $0.60 million for H1 2025.
- Cash and cash equivalents increased to $19.44 million as of June 30, 2026, from $8.12 million at Dec 31, 2025.
- Total assets grew to $21.04 million as of June 30, 2026, from $8.43 million at Dec 31, 2025.
- Net cash provided by financing activities was $14.82 million for H1 2026.
- Research and development expenses totaled $1.11 million for H1 2026, up from $0 in H1 2025.
- Accumulated deficit reached $5.79 million as of June 30, 2026.
- Company is a fabless semiconductor firm in the development stage with no revenues.
- Management expects existing cash to support operations for at least one year.
Price Impact
More from PALX